| Literature DB >> 30018594 |
Roma Sinha1, Mathu Malar C2,3, Subhadeep Das2,3, Sonali Das1, Mohammad Shadab1, Rukhsana Chowdhury1, Sucheta Tripathy2,3, Nahid Ali1.
Abstract
Leishmania donovani possesses a complex heteroxenic life cycle where infective metacyclic promastigotes are pre-adapted to infect their host and cope up with intracellular stress. Exploiting the similarities between cultured and sandfly derived promastigotes, we used early and late passage cultured promastigotes to show specific changes at genome level which compromise pathogen fitness reflected in gene expression and infection studies. The pathogen loses virulence mostly via transcriptional and translational regulations and long-time cultivation makes them struggle to convert to virulent metacyclics. At the genomic level very subtle plasticity was observed between the early and the late passages mostly in defense-related, nutrient acquisition and signal transduction genes. Chromosome Copy number variation is seen in the early and late passages involving several genes that may be playing a role in pathogenicity. Our study highlights the importance of ABC transporters and calpain like cysteine proteases in parasite virulence in cultured promastigotes. Interestingly, these proteins are emerging as important patho-adaptive factors in clinical isolates of Leishmania. We found that the currently available genome of Leishmania in the NCBI database are from late passages. Our early passage genome can act as a reference for future studies on virulent isolates of Leishmania. The annotated leads from this study can be used for virulence surveillance and therapeutic studies in the Indian subcontinent.Entities:
Keywords: Leishmania donovani; genome plasticity; genomics; in vitro passage; promastigotes
Year: 2018 PMID: 30018594 PMCID: PMC6037818 DOI: 10.3389/fmicb.2018.01279
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Summary of assembly statistics for early passage (HTI4), late passage (HTI5) and Genbank Leishmania donovani LdBPK282A1 genomes.
| Assembly name | Number of contigs | Number of chromosomes | Total assembly size (in bases) | Largest chromosome (in bases) | Smallest chromosome (in bases) | Gaps (in bases) | N50 and GC% |
|---|---|---|---|---|---|---|---|
| HTI4 | 2382 | 36 | 32196393 | 2743999 | 284264 | 3663498 | 1058081, 59% |
| HTI5 | 2445 | 36 | 32148377 | 2714535 | 283355 | 3653324 | 1058043, 58% |
| LdBPK282A1 (GCA_000227135.2) | 2152 | 36 | 32444968 | 2713248 | 283432 | 1192833 | 1024085, 59% |
Gene prediction statistics for early (HTI4) and late (HTI5) passages using companion server.
| Genome name | Gene | Protein coding | ncRNA | Pseudo | snRNA | SnoRNA | tRNA |
|---|---|---|---|---|---|---|---|
| HTI-4 Early passage (2nd) | 7656 | 7563 | 14 | 73 | 2 | 1 | 67 |
| HTI-5 Late passage (25th) | 7643 | 7552 | 15 | 82 | 2 | 1 | 66 |
| LdBPK282A1 (GCA_000227135.2) | 8079 | 7967 | 37 | 54 | 0 | 0 | 64 |
Gene Copy number in early, late passages and Genbank strain LdBPK282A1.
| Gene product | Family size | Distribution on chromosomes | ||||
|---|---|---|---|---|---|---|
| HTI4 | HTI5 | LdBPK282A1 | HTI4 | HTI5 | LDBPK282A1 | |
| Kinesins | 51 | 50 | 49 | Scattered | Scattered∗ | Scattered∗ |
| Protein kinases | 259 | 258 | 255 | Scattered | Scattered∗ | Scattered∗ |
| MAP kinases | 17 | 17 | 19 | Scattered∗ | Scattered∗ | Scattered |
| Amastins | 14 | 15 | 26 | 10,24,28,30,34,36 | 10,24,28,30,34,36 | 8,24,28,29,30,34 |
| PSA2 (GP46) metalloproteases | 28 | 29 | 29 | Scattered∗ | Scattered | Scattered |
| Serine peptidases | 17 | 18 | 13 | Scattered | Scattered | Scattered |
| Protein phosphatase | 120 | 118 | 86 | Scattered | Scattered | Scattered |
| Tuzins | 4 | 4 | 6 | 8, 29∗,34 | 8, 29∗,34 | 8,29,34 |
| Amino acid permeases | 15 | 15 | 18 | Scattered∗ | Scattered∗ | Scattered |
| HSP | 11 | 12 | 10 | Scattered∗ | Scattered∗ | Scattered |
| Calpain-like cysteine peptidase | 29 | 31 | 26 | 4,17,18,20(7),21,25, 27(5),31(6),32,33,36 | 4,17,18,20(8),21,25, 27(4),31(7),32,33,34, 36 | 4,14,18,20(8),21, 25,27,30,31(5),32,33,34 |
| Phosphoglycan β 1,3 galactosyltransferases | 3 | 4 | 10 | 2∗,14,31∗,36∗# | 2∗,14,31∗,36∗# | 2,14,31,36 |
| Dynein heavy and light chain | 44 | 44 | 44 | Scattered | Scattered | Scattered |
| Helicases | 84 | 84 | 72 | Scattered | Scattered | Scattered |
| Pteridine transporters | 1 | 1 | 2 | 6,10∗# | 6,10∗# | 6,10 |
| Microtubule-associated proteins | 72 | 72 | 72 | Scattered | Scattered | Scattered |
| ABC transporters | 39 | 42 | 39 | Scattered∗ | Scattered | Scattered∗ |
| Vesicle transporters | 4 | 4 | 4 | 11,23,31,32 | 11.23,31,32 | 11,23,31,32 |
| DNAJ protein/chaperone | 61 | 61 | 29∗∗ | Scattered | Scattered | Scattered∗∗ |
| Long-chain fatty acid CoA ligases | 9 | 9 | 9 | 1,3,13,19∗,28,36∗# | 1,3,13,19∗,28,36∗# | 1,3∗∗,13,19∗,28,36∗# |
| Cyclophilins | 1 | 15 | 13∗∗ | 1,6,16,18,22,23,24,25, 30,31,33,35,36 | 1,6,16,18,22,23,24,25, 30,31,33,35,36 | 1,6,16,22,23,25,30,31, 33,35,36 |
| Histone acetyl transferase/histone deacetylase | 8 | 8 | 7∗∗ | 8,14,16,21,24,26,28 | 8,14,16,21,24,26,28 | 8,14,16,21,24,28 |
| Nucleoside hydrolase | 4 | 4 | 3∗∗ | 14,18,26,29 | 14,18,26,29 | 14,18,29 |
List of proteins differentially expressed (≥1.5-folds) between early and late passages identified by MALDI-ToF MS/MS.
| Spot Number | Assembly gap? location∗ | Protein annotation | Accession number of protein | Protein score | Exp/Thr M.W | Exp/ Thr pI | aFold change (MS/MS) | bFold change Values using RNAseq |
|---|---|---|---|---|---|---|---|---|
| 1 | Yes | Constitutive major surface protease | CAC37962.1 | 434 | 68/63.8 | 5.9/6.84 | 0.66 | –0.67 |
| 2 | Yes | Constitutive major surface protease | CAC37962.1 | 393 | 68.5/63.8 | 5.7/6.84 | 0.45 | –0.42 |
| 3 | Yes | GP63, leishmanolysin | XP_001463701.2 | 75 | 69/63.8 | 5.6/6.84 | 0.05 | –0.42 |
| 4 | Yes | GP63, leishmanolysin | XP_001463701.2 | 114 | 40/63.8 | 5.4/6.84 | 0.1 | –0.42 |
| 5 | Yes | Beta tubulin | XP_003878331.1 | 347 | 55.8/49.7 | 5.2/4.71 | 6.38 | 0.22 |
| 6 | Yes | Putative heat shock 70-related protein 1, mitochondrial precursor | XP_003877392.1 | 271 | 68.5/63.8 | 5.8/6.84 | 0.23 | –0.46 |
| 8 | Chr36: 1099755–1098367 | Putative dihydrolipoamide acetyltransferase precursor | XP_001469441.1 | 382 | 62.4/48.62 | 6.4/7.02 | 0.44 | –0.76 |
| 9 | Yes | ∗∗Activated C kinase protein, partial | ABS82039.1 | 103 | 31.2/30.63 | 6.7/6.63 | 0.66 | –0.20 |
| 10 | Chr32: 766497–767468 | Putative heat shock protein-like protein | XP_001467884.1 | 308 | 22.5/35.49 | 5/4.94 | 0.32 | –0.24 |
| 11 | chr36: 2665342–2666118 | Conserved hypothetical protein | XP_001469385.1 | 703 | 24/29.12 | 5.4/5.82 | 0.24 | 0.54 |
| 12 | chr25: 350814–352157 | ∗∗Gamma tubulin | XP_003860740.1 | 274 | 22.9/49.7 | 5.2/4.71 | 0.28 | –0.16 |
| 13 | chr23: 9640–10320 | ∗∗Mitochondrial peroxiredoxin | AAX73294.1 | 314 | 20.6/25.34 | 5.4/6.43 | 0.27 | –0.82 |
| 14 | chr22: 569013–569636 | i/6 autoantigen-like protein | XP_001465646.1 | 156 | 26.2/23.01 | 6/5.68 | 0.37 | –0.03 |
| 15 | chr36: 1493409–1494356 | Hypothetical protein, conserved (MORN repeat) | XP_003865511.1 | 142 | 18.1/35.67 | 4.8/5.90 | 0.22 | –0.16 |
| 16 | chr35: 896773–897597 | Putative RNA-binding protein | XP_003392812.1 | 344 | 22.6/30.25 | 6.5/7.85 | 0.61 | –0.05 |
| 17 | chr20: 601988–602383 | Putative small myristoylated protein-1 | XP_001465265.1 | 56 | 17.4/12.94 | 6.4/4.70 | 1.96 | 0.56 |
| 18 | chr35: 552681–553127 | ∗∗Putative ubiquitin-conjugating enzyme E2 | XP_001568232.1 | 46 | 13.1/16.65 | 6.3/6.08 | 0.43 | –0.03 |
| 19 | chr23: 133149–134204 | Putative NADP-dependent alcohol dehydrogenase | XP_001465717.1 | 388 | 43.2/38.45 | 6.5/5.96 | 0.54 | –1.48 |
| 20 | chr25: 458908–460485 | Putative ATPase beta subunit | XP_001466152.1 | 211 | 60.5/56.32 | 5.5/5.14 | 2.06 | 0.62 |
| 21 | chr28: 488208–489566 | ∗∗Phenylalanine-4-hydroxylase | XP_001684410.1 | 71 | 48.8/51.48 | 6.2/5.93 | 0.37 | –0.21 |
| 22 | chr36: 2726362–2727795 | ∗∗Protein disulfide isomerase | XP_001469404.1 | 206 | 55.5/52.34 | 5.5/5.42 | 0.34 | –0.23 |
| 23 | chr25: 671470–672522 | Putative pyruvate dehydrogenase E1 beta subunit | XP_001466210.1 | 72 | 45.8/37.84 | 5.5/5.64 | 0.27 | –2.02 |
| 24 | Yes | Alpha tubulin | XP_003873239.1 | 113 | 14.9/49.75 | 4.8/4.89 | 0.35 | –0.04 |
| 25 | chr21: 9660–11141 | Conserved hypothetical protein | XP_001564720.1 | 55 | 23.4/52.12 | 5.6/6.45 | 0.43 | –0.13 |
| 26 | chr21: 413285–414697 | Alpha tubulin | XP_003873239.1 | 68 | 11.3/49.75 | 5.6/4.89 | 0.36 | –0.04 |
| 27 | chr7: 303267–303773 | Conserved hypothetical protein/putative Qa-SNARE protein | XP_003872214.1/ XP_001463282.1 | 59 | 11.5/14.35 | 5.2/9.15 | 0.52 | –1.24 |
| 28 | Yes | Conserved hypothetical protein | XP_001470159.1 | 82 | 33.5/24.26 | 5.6/5.71 | 0.61 | –0.62 |
| 29 | chr28: 460266–462242 | ∗∗Putative glucose-regulated protein 78 | XP_001470161.1 | 207 | 75.2/71.94 | 5.5/5.05 | 1.55 | 0.04 |
| 30 | Yes | ∗∗Putative calmodulin | XP_001463554.1 | 50 | 55/70.47 | 5.6/4.41 | 0.45 | –0.54 |
| 31 | Yes | ∗∗ | XP_003392704.1 | 73 | 48.5/43.12 | 6.1/5.49 | 0.45 | –0.08 |
| 32 | Chr30:122: 5029–1226102 | Conserved hypothetical protein | XP_001467184.1 | 115 | 30.2/40.83 | 5.9/5.32 | 0.11 | –0.16 |
| 33 | chr36: 1115280–1116995 | ∗∗Mitochondrial ATP-dependent zinc metallopeptidase, putative, metallo-peptidase, Clan MA(E), Family M41 | CCM19617.1 | 52 | 19.47/72.38 | 5.7/8.49 | 0.57 | –0.99 |
| 34 | chr11: 473373–474023 | Elongation factor 1-alpha | XP_003392396.1 | 112 | 52.36/49.12 | 6.8/9.03 | 0.61 | –1.31 |
| 35 | chr25: 548571–549221 | Putative GTPase | XP_001463009.1 | 223 | 12.4/24.24 | 5.9/6.09 | 0.29 | –0.31 |